SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in WHWK — Whitehawk Therapeutics, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in WHWK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$701,954
+$435,554 QoQ
Shares Held
203,465
+84.8% QoQ
Ownership
0.357%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WHWK Over Time
Shares Held
Position Value (USD)
Derivatives in WHWK
reported options exposure · as of Dec 31, 2022CallValue
$401,579
CallShares
31,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in WHWK
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $701,954 | 203,465 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $266,400 | 110,083 | Shares | Other | 2026-02-17 | |
| 2025-03-31 | $93,425 | 52,486 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $181,447 | 57,511 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $148,206 | 71,945 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $145,899 | 99,931 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $90,593 | 38,715 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $63,512 | 31,442 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $65,519 | 13,537 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $142,511 | 20,835 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $158,983 | 21,959 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $401,579 | 31,300 | Call | Defined | 2023-02-14 | |
| 2022-09-30 | $1,011,708 | 71,600 | Call | Defined | 2022-11-14 | |
| 2022-06-30 | $373,369 | 30,306 | Shares | Defined | 2022-08-15 | |
| 2022-06-30 | $976,976 | 79,300 | Call | Defined | 2022-08-15 | |
| 2022-03-31 | $1,637,282 | 96,481 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $919,774 | 54,200 | Call | Defined | 2022-05-16 | |
| 2021-12-31 | $530,261 | 21,957 | Shares | Defined | 2022-04-05 | |
| No filing history on record for this holder in this stock. | ||||||